Actuate Therapeutics Inc logo

ACTU

HEALTHCARE

Actuate Therapeutics Inc

$2.99-0.08 (-2.61%)PRE

Live · NASDAQ · May 9, Close

AI Insight

What's Moving ACTU Today?

No stock-specific AI insight has been generated for ACTU yet. Check back soon — insights are generated from recent news analysis.

52-Week Range

$1.58$11.99

$2.99

Fundamentals

Market Cap$71M
P/E Ratio
EPS$-1.06
Dividend Yield
Dividend / Share
ROE-5.5%
Profit Margin
Debt / Equity

Trading

Volume105K
Avg Volume (10D)
Shares Outstanding23.7M

ACTU News

20 articles

All 20 articles loaded

Price Data

Open$3.08
Previous Close$3.07
Day High$3.15
Day Low$2.91
52 Week High$11.99
52 Week Low$1.58

About Actuate Therapeutics Inc

Actuate Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing groundbreaking therapies for patients with serious diseases, particularly in the oncology sector. The company is progressing its proprietary drug candidates through comprehensive clinical trials to address significant unmet medical needs, thereby enhancing patient outcomes. With a commitment to innovative therapeutic approaches, Actuate is cultivating a strong pipeline that not only aims for strategic growth but also seeks to deliver substantial value to investors, solidifying its position in the biotechnology industry.

12 employees
Listed August 13, 2024
HEALTHCAREBIOTECHNOLOGY

Company Details

Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot
SICBIOTECHNOLOGY
CIK
Composite FIGI
Share Class FIGI